inglasia pharma solutions specialises in training and consultancy services to the pharmaceutical industry. We promote and educate in best practices for the manufacturing and distribution of Pharmaceutical medicines and medical devices.
Our training and consultancy services and our library of templates, guidance documents and training presentations serve as a framework for organisations to raise the awareness of Quality and its application.
Our clients include large to small pharmaceutical companies. Some of these are listed below.
GSK
SPMSD
Crescent Manufacturing
Crescent Pharma
HennessyMason
Gilead
Yusen
Alexion
PDP Courier
CaligorRx
Lonza Biologics
Galderma
Airliquide
Novartis
Nestlé Skin Health
Company Details
- Employees
- 10
- Founded
- -
- Address
- 207 Regent Street, London,uk W1b 3hh,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- inglasia.com
- Keywords
- Training, Online Training, Consultancy, non-profit training, GMP, GDP, Good Manufacturing Practice, Good Distribution Practice, Pharmaceutical Quality System.
- HQ
- London, UK
Inglasia Pharma Solutions Questions
Inglasia Pharma Solutions's website is inglasia.com
Inglasia Pharma Solutions's LinkedIn profile is https://uk.linkedin.com/company/inglasia-pharma-solutions
Inglasia Pharma Solutions has
10 employees.
View email and phone details for 10
employees at Inglasia Pharma Solutions.
Inglasia Pharma Solutions's industry is
Pharmaceutical Manufacturing
Inglasia Pharma Solutions's top competitors are
Gilead Sciences,
United Therapeutics Corporation,
Teva Pharmaceuticals,
Sigma - Independent Together,
Lanes Health,
Sanofi,
Ascot Laboratories Ltd,
Pfizer,
Bristol Myers Squibb,
Dixons Pharmaceuticals Uk Limited.
Inglasia Pharma Solutions's categories are Pharmaceutical Manufacturing
Inglasia Pharma Solutions's founding year is 2011
